| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.004 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.094 | 0.006 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.006 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.007 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.078 | 0.009 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.076 | 0.01 |